These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Introductory address: treatment of pelvic inflammatory disease in view of etiology and risk factors. Weström L Sex Transm Dis; 1984; 11(4 Suppl):437-40. PubMed ID: 6395378 [TBL] [Abstract][Full Text] [Related]
46. [Local hypothermia in combined treatment of acute inflammatory diseases of uterine appendages]. Isaev AK Vopr Kurortol Fizioter Lech Fiz Kult; 2002; (6):28-9. PubMed ID: 12592903 [No Abstract] [Full Text] [Related]
47. [A low-frequency alternating magnetic field, a supersonic-frequency current and interference currents in the combined treatment of chronic nonspecific endometritis]. Strugatskiĭ VM; Popovich LS Vopr Kurortol Fizioter Lech Fiz Kult; 1997; (4):41-2. PubMed ID: 9424834 [No Abstract] [Full Text] [Related]
48. European guideline for the management of pelvic inflammatory disease. Ross J; Judlin P; Nilas L Int J STD AIDS; 2007 Oct; 18(10):662-6. PubMed ID: 17945043 [TBL] [Abstract][Full Text] [Related]
49. [Complex health resort treatment of patients with inflammatory diseases of the adnexa uteri and vegetovascular disorders]. Gurtskaia LK Vopr Kurortol Fizioter Lech Fiz Kult; 1984; (5):60-1. PubMed ID: 6239447 [No Abstract] [Full Text] [Related]
52. Pelvic inflammatory disease. Eschenbach DA IPPF Med Bull; 1985 Jun; 19(3):1-3. PubMed ID: 12280152 [TBL] [Abstract][Full Text] [Related]
53. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Ness RB; Trautmann G; Richter HE; Randall H; Peipert JF; Nelson DB; Schubeck D; McNeeley SG; Trout W; Bass DC; Soper DE Obstet Gynecol; 2005 Sep; 106(3):573-80. PubMed ID: 16135590 [TBL] [Abstract][Full Text] [Related]
54. [Our experience with antibiotic-enzymatic therapy in the common inflammatory pathology of the female genitalia]. Legittimo C; Degli Albizi S Acta Chir Ital; 1968; 24(3):309-28. PubMed ID: 5709755 [No Abstract] [Full Text] [Related]
55. [Chemotactic potential of phagocytes as a criterion for the efficacy of therapy in inflammatory diseases of the uterine appendages]. Mamedov FM Vopr Kurortol Fizioter Lech Fiz Kult; 2008; (6):41-2. PubMed ID: 19175057 [No Abstract] [Full Text] [Related]
56. [Vibration massage of pain points on the skin in treating chronic adnexal inflammation]. Iudinskikh SV; Radionchenko AA; Kreĭmer AIa; Al'perovich VG Vopr Kurortol Fizioter Lech Fiz Kult; 1983; (3):41-3. PubMed ID: 6623977 [No Abstract] [Full Text] [Related]
57. The role of urogenital trichomonadosis in exacerbation of chronic processes of internal genitalia. Iliev G; Avramov I Wiad Parazytol; 1973; 19(3):367-9. PubMed ID: 4732792 [No Abstract] [Full Text] [Related]
58. [Adnexitis therapy using chymotrypsin "Berlin-Chemistry"]. Linz O Z Arztl Fortbild (Jena); 1972 Feb; 66(3):153-9. PubMed ID: 5047086 [No Abstract] [Full Text] [Related]
59. [Lymphozil in chronic inflammatory adnexal diseases]. BEUTHE D Munch Med Wochenschr; 1959 Feb; 101(7):282-4. PubMed ID: 13644085 [No Abstract] [Full Text] [Related]
60. [Continuity in the treatment of inflammatory diseases of the female genitalia between the hospital and maternity center]. Romanovskaia NP Akush Ginekol (Mosk); 1971 Feb; 47(2):34-6. PubMed ID: 5118537 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]